<DOC>
	<DOCNO>NCT01652118</DOCNO>
	<brief_summary>The purpose study determine clarithromycin effect develop bronchopulmonary dysplasia preterm baby .</brief_summary>
	<brief_title>Clarithromycin Prophylaxis Preterm Infants Colonisation With Ureaplasma Urealyticum Mycoplasma Hominis</brief_title>
	<detailed_description>The investigator plan clarithromycin treatment preterm baby 1250 gram birth weight . The investigator aim treatment , bronchopulmonary dysplasia rate preterm baby may decrease .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>infant must 1250 gram birth weight Major congenital anomaly , CardiaC abnormality , without inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>bronchopulmonary dysplasia</keyword>
	<keyword>clarithromycin</keyword>
	<keyword>preterm baby</keyword>
</DOC>